Chimeric Therapeutics Advances CHM 2101 Viral Vector Manufacture

miragenews.com

1 year ago

Cell therapy company Chimeric Therapeutics (ASX:CHM) has completed the manufacturing and quality release for CHM 2101 viral vector. The company says